The blood-brain barrier (BBB) is composed of four cell populations, brain endothelial cells (BECs), pericytes, neurons, and astrocytes. Its role is to precisely regulate the microenvironment of the brain through selective substance crossing. Here we generated an in vitro model of the BBB by differentiating human induced pluripotent stem cells (hiPSCs) into all four populations. When the four hiPSC-derived populations were co-cultured, endothelial cells (ECs) were endowed with features consistent with BECs, including a high expression of nutrient transporters ( CAT3, MFSD2A) and efflux transporters ( ABCA1, BCRP, PGP, MRP5), and strong barrier function based on tight junctions. Neuron-derived Dll1, which activates Notch signaling in ECs, was essential for the BEC specification. We performed in vitro BBB permeability tests and assessed ten clinical drugs by nanoLC-MS/MS, finding a good correlation with the BBB permeability reported in previous cases. This technology should be useful for research on human BBB physiology, pathology, and drug development.
BBB are generated with hiPSC-derived BECs, pericytes, neurons, and astrocytes
ciBECs highly express BBB-specific transporters and showed barrier function
Mechanism of ciBEC specification activates Notch signaling via Dll1 in neurons
BBB permeability of clinical drugs by nanoLC-MS/MS correlates with previous cases
Yamamizu and colleagues generated an in vitro model of the BBB by differentiating hiPSCs into brain endothelial cells (BECs), pericytes, neurons, and astrocytes. They found that neuron-derived Dll1, which activates Notch signaling in ECs, was essential for the BEC specification. They also performed in vitro BBB permeability tests and assessed clinical drugs by nanoLC-MS/MS, finding a good correlation with the clinical cases.